Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. - Wikidata - wikimedia - TriplyDB

Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

http://www.wikidata.org/entity/Q36330867

about

Homeostasis and inflammation in the intestine Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Function of Nod-like receptors in microbial recognition and host defense Role of regulatory T cell in the pathogenesis of inflammatory bowel disease Pattern Recognition Receptors in Cancer Progression and Metastasis Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases NOD-Like Receptors: Master Regulators of Inflammation and Cancer The TNBS-induced colitis animal model: An overview Holding the inflammatory system in check: NLRs keep it cool NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling A functional role for Nlrp6 in intestinal inflammation and tumorigenesis Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma Inflammatory bowel disease Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.Interactions between the host innate immune system and microbes in inflammatory bowel disease.The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.Pathogen recognition receptors, cancer and inflammation in the gut.Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes Immune responses upon Campylobacter jejuni infection of secondary abiotic mice lacking nucleotide-oligomerization-domain-2.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.Molecular control of steady-state dendritic cell maturation and immune homeostasis.NOD-like receptors in intestinal homeostasis and epithelial tissue repair.Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium.The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways Toll-like receptors in inflammatory bowel diseases: a decade later.Intestinal epithelial cells in inflammatory bowel diseases.Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.Nod2: a key regulator linking microbiota to intestinal mucosal immunity.A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1.Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages Genetic deletion of dectin-1 does not affect the course of murine experimental colitis.NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

P2860

Q24613509-696D3A9D-2CF9-4395-8D18-179C4CB53474 Q24631660-542A8770-B4D5-444C-9A43-1AD035E5293C Q24647448-29272080-A064-4C6A-8229-C67D3DA659AF Q26768560-7A641317-A3C5-47B4-BAE6-0364BFA45A0B Q26798034-358D86AA-8558-4E1B-A7CB-76329B74B490 Q26864035-53BADCB7-844E-4647-A09B-FF9855599632 Q26865199-BBDE9D10-D6D5-44AA-A6F1-44065E5DE39D Q28077599-E2C151B7-086B-4A34-8538-2A794228B3C4 Q28081065-E8B0ACD7-535C-4BE6-A02B-30D60ADAAD9E Q28505592-C41F3775-849D-4FC5-B731-562FBB901853 Q28508154-A0CF437E-0FD1-4AC6-8217-C8DC543BDCCD Q28587904-D151E0CD-1BB7-4DB1-BBA6-4C235B2AA223 Q29616286-93E513D8-70E8-4905-94AF-69F8A2857361 Q30423121-B0DAF1D3-623B-4562-BB84-88FCFBFAC514 Q30497993-3EA60438-E48D-46DB-90C1-99E1640359AC Q30882927-63C75D0C-8E40-444C-94AA-1A69DC75BA93 Q33554402-68213E02-6EF4-4F49-ADBC-E7104A04FA28 Q33583832-5872B8E3-FC56-41A2-9A5B-2BEB6BDE3A75 Q33680511-F8F34F04-C12B-437B-A93F-C6041C5E3CEF Q33711741-98DB553D-020A-4419-8E15-64001C4406CD Q33719311-BBBD1B9E-DDCA-4DFE-B07C-64B4D912EA8D Q33771702-42F1D4C9-CB0C-433A-B60A-8F501FC567F0 Q33815718-CBEC21CA-3A6C-4B26-BE5A-086E43A84632 Q33841037-7BD7D334-F82B-4CEB-84E5-0D17A777E36F Q33882051-352BF015-CC67-42ED-8EB8-54E22C688BED Q33907548-636E91A1-5F7E-4E81-8B8C-DE61D7B3168C Q34091864-22193955-E9FE-4E08-8048-8F71E6CA4822 Q34097022-0659521C-F420-498E-953B-6B6DB327BCDA Q34134813-F3B38F41-9F9A-4468-9C51-2DF884B95AAE Q34136264-20FA9838-5C4A-4153-A5EB-0128ECFBB69E Q34146736-31C3B738-4AED-4C68-89BF-079009B41383 Q34154459-C297EAFB-D9EE-4800-9742-96C6B2FE40B3 Q34209010-836D11D3-367A-4358-B300-DBC679325D97 Q34210133-46EE1BD8-0869-473A-92D1-2A176236056B Q34218146-EF5F58EF-5434-47C6-978E-0FAF3A1052D1 Q34218985-FD1B2C5C-B5E7-457F-880E-CEAC9C828A76 Q34234483-45FC3F99-75A0-4A09-8164-E8F2D41E0F03 Q34253078-BA7ED2FE-1789-4EEA-AD47-C26E2E32D312 Q34307355-8B39833B-C6B9-46EA-B199-39A797DE6665 Q34407175-47B2B189-6BB3-4D56-90BC-64659BDFFCC7

P2860

Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

http://www.wikidata.org/entity/Q36330867

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Muramyl dipeptide activation o ...... ice from experimental colitis.

@ast

Muramyl dipeptide activation o ...... ice from experimental colitis.

@en

type

label

Muramyl dipeptide activation o ...... ice from experimental colitis.

@ast

Muramyl dipeptide activation o ...... ice from experimental colitis.

@en

prefLabel

Muramyl dipeptide activation o ...... ice from experimental colitis.

@ast

Muramyl dipeptide activation o ...... ice from experimental colitis.

@en

P1433

Q36330867-578B8513-225D-4426-9096-9CEDE128A305

P1476

Q36330867-053D4009-9068-4937-B546-4A79AC89E001

P2093

Q36330867-1054BA57-82D6-4242-BB6D-53AC4B31B5BD

Q36330867-1DA3DCE5-14D1-4AA7-B133-7FC08CC9225F

Q36330867-27A617C2-EF18-41FF-A1A8-4DE0A891051F

Q36330867-31E4BAF3-AF8F-45B8-B683-0B669999D89A

Q36330867-9859C86B-224E-4DF8-AD80-62BBA8243453

Q36330867-A9592F98-6FF4-43E0-9429-BFB7F5A5EA2E

Q36330867-BE632F0F-CF8A-4379-99B3-3AB9FBD8D944

P2860

Q36330867-04475A80-0997-42E2-87B6-B3539B58ABB7

Q36330867-0EBDE078-677F-45EF-B539-FE4E4123FFE9

Q36330867-14B42A66-50E2-41D3-B3B9-7DE987387F4C

Q36330867-228D6855-CCDF-459A-A226-7A0E44B0CF3E

Q36330867-2F87B573-B5AA-435F-9A5F-FA11A1CDF853

Q36330867-4292C00A-30A5-40C9-BF31-1770E6F1F0D0

Q36330867-4396981A-078D-4519-8D6D-E26E368F2979

Q36330867-474C3319-C5E7-464B-A4D4-F3A6AD395CA6

Q36330867-47D0E537-BBD5-4700-8E74-EEE932C0307D

Q36330867-4A1739E9-B9A9-4DD6-A534-40E40711075B

P304

Q36330867-680E9CE8-85C3-429A-AE3B-4B2D3ADAA533

P31

Q36330867-A865F7DE-7B04-4F34-8CFC-862FEF1F0559

P356

Q36330867-A36D2315-1BDB-46E9-B483-3062B46D56AC

P407

Q36330867-1BF398EE-3481-4953-B8BE-5DE1374B55B0

P433

Q36330867-10D5AA0C-FE2D-408F-8B1E-9BDFC5043CB9

P478

Q36330867-55FBBF58-51D2-45FE-A915-53F66261665B

P50

Q36330867-54D6D3BE-1C18-48DB-AAB0-AA8330013594

P577

Q36330867-B81AACF3-4C69-4888-BE9C-46F160C78C45

P698

Q36330867-72FA9BA1-F92C-4B65-B96C-A1132608BCE2

P932

Q36330867-964FDCFF-635A-4415-A0CE-90D5EB7DC18A

P356

P1433

Journal of Clinical Investigation

P1476

Muramyl dipeptide activation o ...... mice from experimental colitis

@en

P2093

Atsushi Kitani

http://www.w3.org/2001/XMLSchema#string

Ivan J Fuss

http://www.w3.org/2001/XMLSchema#string

Keiko Ozato

http://www.w3.org/2001/XMLSchema#string

Peter J Murray

http://www.w3.org/2001/XMLSchema#string

Prafullakumar Tailor

http://www.w3.org/2001/XMLSchema#string

Tomohiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Warren Strober

http://www.w3.org/2001/XMLSchema#string

P2860

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

IRAK-M is a negative regulator of Toll-like receptor signaling

A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

Anti-interleukin-12 antibody for active Crohn's disease

Signalling pathways and molecular interactions of NOD1 and NOD2

Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis

Negative regulation of Toll-like-receptor signaling by IRF-4.

P304

545-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI33145

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18188453

http://www.w3.org/2001/XMLSchema#string

P932

2176188

http://www.w3.org/2001/XMLSchema#string